Inventor
KLING LOTHAR
DE17 patents
⚠️ This page may combine multiple inventors who share the name “KLING LOTHAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
6 patentsUS7405231B2Jul 29, 2008
Oxidized thioether derivatives
HOFFMANN LA ROCHE2 citations62
US7005526B2Feb 28, 2006
Thioether derivatives
HOFFMANN LA ROCHE3 citations62
US7625896B2Dec 1, 2009
Pyridylsulfonamide derivatives
HOFFMANN LA ROCHE3 citations61
US7429605B2Sep 30, 2008
Phenylpyridine derivatives
HOFFMANN LA ROCHE4 citations59
US7879884B2Feb 1, 2011
Aryl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
HOFFMANN LA ROCHE0 citations51
US7939532B2May 10, 2011
Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
HOFFMANN LA ROCHE0 citations50
BOEHRINGER MANNHEIM GMBH
5 patentsUS4882342ANov 21, 1989
5-alkylbenzimidazoles, method of use and pharmaceutical compositions
BOEHRINGER MANNHEIM GMBH48 citations92
US5486530AJan 23, 1996
Use of torasemide for the treatment of brain oedemas
BOEHRINGER MANNHEIM GMBH20 citations88
US4925845AMay 15, 1990
2 heteroaryl 3,3 dialkyl-5-(3 oxo-2,3,4,5 tetrahydro-6 pyridazinyl)-3H-indoles
BOEHRINGER MANNHEIM GMBH11 citations73
US4870077ASep 26, 1989
Heterocyclic substituted indolinones
BOEHRINGER MANNHEIM GMBH3 citations62
US5888967AMar 30, 1999
Use of plasminogen activators to stimulate local bone growth
BOEHRINGER MANNHEIM GMBH4 citations60
ROCHE DIAGNOSTICS GMBH
3 patentsUS6429288B1Aug 6, 2002
Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds
ROCHE DIAGNOSTICS GMBH24 citations90
US6197759B1Mar 6, 2001
Osteoblast-specific mitogens and drugs containing such compounds
ROCHE DIAGNOSTICS GMBH4 citations62
US6911553B1Jun 28, 2005
Osteoblast-specific mitogens and drugs containing such compounds
ROCHE DIAGNOSTICS GMBH0 citations51